Show simple item record

dc.contributor.authorAnyama, Norbert G.
dc.contributor.authorTibenderana, James K.
dc.contributor.authorKutyabami, Paul
dc.contributor.authorKamba, Pakoyo F.
dc.contributor.authorKitutu, Freddy E.
dc.contributor.authorAdome, Richard O.
dc.date.accessioned2022-02-03T10:22:10Z
dc.date.available2022-02-03T10:22:10Z
dc.date.issued2012
dc.identifier.citationAnyama, N. G., Tibenderana, J. K., Kutyabami, P., Kamba, P. F., Kitutu, F. E., & Adome, R. O. (2012). Participatory healthcare-provider orientation to improve artemether-lumefantrine-based drug treatment of uncomplicated malaria: a cluster quasi-experimental study. BMJ quality & safety, 21(9), 768-777. doi:10.1136/bmjqs-2010-049270en_US
dc.identifier.other10.1136/bmjqs-2010-049270
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/1819
dc.description.abstractTo assess the effect of participatory healthcare-provider orientation in enhancing patient knowledge, appropriate prescribing and dispensing of artemether-lumefantrine, during drug treatment of uncomplicated malaria. Methods: A cluster quasi-experimental study. The authors developed strategies to address challenges encountered by healthcare providers during clinical management of malaria. The primary outcome was patient knowledge on prescribed malaria drug treatment. Secondary outcomes were appropriate prescribing and provision of adequate drug dispensing information. The authors used generalised estimating equation logistic regression to investigate correlates of appropriate use of artemether-lumefantrine. Results: The proportion of patients or caretakers of paediatric patients sufficiently knowledgeable about malaria treatment increased from 16/85 (18.8%) at baseline to 33/96 (34.4%) at evaluation, OR 2.26 (95% CI 1.13 to 4.49), p¼0.020, in the intervention, and fell slightly from 49/134 (36.6%) to 35/114 (30.7%), OR 0.77, (95% CI 0.45 to 1.31), p¼0.331 in the control district. This was enhanced by the existence of drugdispensing standard operating procedures (adjusted OR 1.85, 95% CI 0.98 to 3.50; p¼0.057). The proportion of appropriate prescriptions increased from 61/87 (70.1%) to 94/112 (83.9%) in the intervention district, OR 2.23 (95% CI 1.13 to 4.40), p¼0.020 and reduced from 91/115 (79.1%) to 75/112 (67.0%) in the control district, OR 0.53, (95% CI 0.29 to 0.97), p¼0.040. The frequency of adequately dispensed prescriptions increased in the intervention district (34 (32.4%) to 53(45.3%), OR 1.73 (95% CI 1.00 to 2.99), p¼0.050) but decreased in the control location (94 (69.6%) to 71 (52.6%), OR 0.48 (95% CI 0.29 to 0.80), p¼0.004). Conclusions: Participatory healthcare-provider orientation enhanced patient knowledge, healthcare provider prescribing and dispensing of artemether-lumefantrine, bolstered by adequate medication counselling and use of drug-dispensing standard operating procedures.en_US
dc.language.isoenen_US
dc.publisherBMJ quality & safetyen_US
dc.subjectHealthcare-provideren_US
dc.subjectArtemetherlumefantrine-based drug treatmenten_US
dc.subjectMalariaen_US
dc.subjectCluster quasi-experimental studyen_US
dc.titleParticipatory healthcare-provider orientation to improve artemetherlumefantrine-based drug treatment of uncomplicated malaria: a cluster quasi-experimental studyen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record